| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.0% | |
| Div Cover | 3.7 | |
| Op Mrgn | 6.1% | |
| ROCE | 14.0% |
| Latest | F'cast | |
|---|---|---|
| P/E | 26.7 | |
| PEG | 0.9 | |
| Pr/Revenue | 2.4 | |
| Pr/Book | 4.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 14.1% | |
| PBT | 469.6% | |
| EPS | 30.5% | |
| DPS | 5.6% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-21 | 248.30 | (35.60) | 60.60¢ | 43.2 | n/a | -38% | 44.90¢ | 1.7% |
| 30-Sep-22 | 263.50 | 6.00 | 54.70¢ | 27.8 | n/a | -10% | 44.90¢ | 3.0% |
| 30-Sep-23 | 243.80 | (20.20) | 40.30¢ | 20.9 | n/a | -26% | 29.60¢ | 3.5% |
| 30-Sep-24 | 275.00 | 2.30 | 69.90¢ | 23.6 | 0.3 | +73% | 23.30¢ | 1.4% |
| 30-Sep-25 | 313.90 | 13.10 | 91.20¢ | 31.2 | 1.0 | +30% | 24.60¢ | 0.9% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-26 | 336.94 | 51.54 | 87.41p | 20.6 | n/a | -4% | 23.70p | 0.0% |
| 30-Sep-27 | 359.47 | 56.44 | 98.31p | 18.3 | 1.5 | +12% | 27.11p | 0.0% |
| 30-Sep-28 | 387.32 | 61.50 | 111.32p | 16.2 | 1.2 | +13% | 31.08p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 23-Dec-2025 | 09:21 | RNS |
| Appointment of Chief Executive Officer | 17-Oct-2022 | 07:00 | RNS |
| Director/PDMR Shareholding | 23-Dec-2025 | ShareCast |
| Drug film probe | 22-Apr-2008 | Sun |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1,824.00p |
| Change Today | -0.24p |
| % Change | -1.32 % |
| 52 Week High | 2,175.00 |
| 52 Week Low | 1,335.00 |
| Volume | 2,323 |
| Shares Issued | 31.02m |
| Market Cap | £565.86m |
| Strong Buy | 3 |
| Buy | 1 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 7 |

| Time | Volume / Share Price |
| 12:29 | 31 @ 1,800.00p |
| 12:29 | 50 @ 1,804.00p |
| 12:29 | 11 @ 1,804.00p |
| 12:25 | 61 @ 1,810.00p |
| 12:25 | 17 @ 1,810.00p |
| Chair | Bruce Thompson |
| CFO | Rich Cashin |
You are here: research